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Abstract 
 
The purpose of this working paper is to contribute towards the continuing 
debate on the nature of class structure in the West, recognising that 
occupation has constituted the central device in the construction of 
theoretical approaches in this area. The paper is critical of the notion that 
there can be a simple congruence between occupation and class, but is 
nevertheless committed to the view that the workplace remains a key site 
wherein class antagonisms are played out.  
 
Using primary data the paper explores workplace relations between 
research scientists and their employing organisation, a major 
pharmaceutical firm.  It considers theoretical approaches to locating these 
‘middle layers’ and in particular the suggestion that they form a new 
‘service class’. 
 
The paper concludes that there are weaknesses in the notion of a service 
class both theoretically and in practice and argues that Marxist theories of 
class, and labour process theories concerned with management control, 
have significant explanatory power when applied to the interview data 
presented here. Rather than witnessing the growth of a service class and 
the death of the working class, the paper argues, we are seeing it 
transformed and re-generated. 
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1. Introduction 
 
The purpose of this paper is to contribute towards the continuing debate 
on the nature of class structure in the West, recognising that occupation 
has constituted the central device in the construction of theoretical 
approaches in this area (Parkin 1972, Reid 1981).  The paper is critical of 
the notion that there can be a simple congruence between occupation and 
class, but is nevertheless committed to the view  that the workplace 
remains a key site wherein class antagonisms are played out. The paper 
explores workplace relations between research scientists – an archetypal 
group of ‘knowledge workers’ - and their employing organisation, a major 
pharmaceutical firm.  
 
The growth in the number and importance of professional and scientific 
occupations in the developed economies during the post-war period has 
been used by several authors working within a Marxist tradition as 
evidence of the development of a new class between the bourgeoisie and 
the working class (see  Ehrenreich and Ehrenreich 1979, Poulantzas 
1975, Carchedi 1977, Goldthorpe 1982, Abercrombie and Urry 1983). The 
terminologies used by these authors to describe this ‘new middle class’, 
as well as the analyses of its composition, vary and have been considered 
fully elsewhere (Smith 1987). However, the impact of the development of 
a service and consumer society on both class structure and the perception 
of class has been widely reported. While there is no analytical connection 
between the notion of a ‘service society’ and a ‘service class’ this latter 
approach to class analysis (Goldthorpe 1982, Abercrombie and Urry 1983) 
has considerable currency (Li et al 2002). Consequently, from amongst 
those theories that argue the case for a new middle class, greater 
consideration will be given to this particular approach. Others, also 
working within a Marxist tradition have, by contrast, identified a process of 
proletarianisation of professionals during the twentieth century, as they 
move from self-employed to salaried status and become subject to the 
twin constraints of hierarchy and the division of labour imposed by the 
modern capitalist organisation (Braverman 1974).  
 
The paper begins with a brief description of the empirical study on which it 
later reports and then goes on to consider the role of scientists within 
industry.  A short section follows which describes the historical 
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development of the Pharmaceutical industry and its competitive 
environment since the end of the Second World War. This is necessary in 
order to understand the forces working to reshape the employment 
relationship. The next section of the paper is devoted to a discussion of 
theories of class and the middle layers of employment and this is followed 
by a consideration of evidence arising from the empirical data gathered 
during the study. Finally some conclusions are drawn. 
 
 
2. Empirical Basis of the Paper  
 
The paper is based on a case study of research scientists employed in the 
UK R&D Division of a major pharmaceutical company. Eighty semi-
structured interviews were carried out with scientists, their immediate and 
senior managers and members of the HR function over a five year period.  
The interviews, which were recorded and transcribed, were subject to a 
detailed qualitative analysis. 
 
The study focussed in particular on the management of research science 
and examined issues emerging from the relationship between this group 
and their employing organisation (referred to here as Pharmco). A key 
consideration was the nature, purpose and perception of bureaucratic 
control mechanisms imposed by management and in some cases widely 
contested by employees.  The study (Randle 1999) locates the 
development of and opposition to such control mechanisms within an 
analytical framework (Labour Process Theory) which identifies them as 
central to the relations of production. 
 
During the course of the study Pharmco was involved in a merger with 
another large Pharma company. As a result of this the data consists of 
interviews with a sample of employees working for Pharmco prior to the 
merger and a second interview with those who remained with the merged 
company, eighteen months later, following a major redundancy operation. 
The merger, it is argued, led to sharp discontinuous change which had a 
significant impact on the way in which scientists viewed their employing 
organisation and experienced their work.  Furthermore, the case provides 
us with an opportunity to consider empirical material that contributes 
towards our understanding of work organisations and class structure and 
processes. 
 
 
3. Scientists in Industry 
 
Forty years ago a seminal study (Kornhauser 1962) noted the rapid 
growth in the number of salaried professional workers in mature industrial 
societies. Massive continuing expansion in the number of organisational 
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professionals especially in Western Europe and the US, has ensured 
ongoing interest in their employment and management in both academic 
and practitioner oriented literatures (Randle 1996). The growth of the 
group has been attributed to the increasing size, complexity, and 
specialised nature of organisations. Furthermore, it includes new 
professions which, it has been suggested, are specifically the product of 
the development of the modern, science-based organisation (Ibid). 
 
The most significant boost to the employment of scientists in industry can 
be traced to the development during the twentieth century of laboratories 
within manufacturing companies, initially with a production support 
function (Reich 1985). Over time laboratories became separated and 
insulated from the immediate demands of production: the genesis of 
corporate R&D. Continued growth in the employment of scientists 
occurred with the expansion of R&D organisations, stimulated in the first 
instance by the Second World War and then by post-war (cold war) 
military spending (Whittington 1991).  
 
However, the 'ivory tower' isolation implied by this development has more 
recently been overtaken by greater integration with other business 
functions. Unlimited R&D funds are a thing of the past and increasingly 
interdisciplinary approaches are necessary in order to solve the difficult 
R&D problems of our time (Miller 1986).  In the US these changes have 
been seen as marking ‘the end of an era for corporate scientific research 
laboratories’ as research is redirected; 
 
 …. toward activities that are more relevant to ongoing 
product and process development, more likely to produce 
results that can be kept proprietary, and more certain to 
produce a commercial payoff in the near future. At the same 
time, to increase productivity and shorten the time required 
to bring new technologies to market, they (managers) have 
restructured and resized their organisations .... (Nelson, 
Rosenbloom and Spencer 1996:229) 
 
The question of how to increase the efficiency of the innovation process 
and improve productivity, against the backdrop of increasing competition, 
has become a particularly critical management problem for the 
pharmaceutical industry (Cookson 1996). In the section which follows we 
consider issues which have permeated much of the sociological literature 
on scientific professionals. 
 7
 
 
3.1  Scientists and Autonomy  
 
Some theorists, perhaps most notably Bell (1973), have elevated salaried 
professionals to a leading position in what was seen in the early 1970s as 
the coming ‘post-industrial’ society.  Bell argues that this ‘post-industrial 
elite’ have been able to maintain an exclusive control over their knowledge 
base and are therefore able to resist management attempts to encroach 
upon their autonomy.  Professionals have actually gained power in 
organisations, he maintains, because of the increased importance to them 
of formalised bodies of professional knowledge. Others have argued that 
professional work involves specialist expertise which is not readily 
available to managers and is often characterised by the indeterminate 
nature of its outcome (Causer and Jones 1996). Littler (1990) maintains 
that the less direct and immediate the relation between activity and 
outcome, the more difficult it becomes to specify with precision the work 
tasks which the specialist or expert should undertake.  
 
There has been a strong focus in the literature that scientists are unique 
as an occupational group and that the so called professional/ bureaucratic 
dilemma (managers’ need for control against the autonomy of the 
professional) is a root cause of conflict within the science based 
organisation (Raelin 1985, Marcus 1985).  The need for, and expectation 
of autonomy at work, clashes with the goals of the organisation. However, 
research in this area is far from conclusive with some theorists 
distinguishing between ‘strategic’ and ‘operational autonomy’ and 
concluding that the demand for operational autonomy is manageable 
(Bailyn 1985).  
 
Others have concluded that corporate R&D is populated by ‘technologists’ 
rather than ‘scientists’ and does not, as a result, embody the traditional 
norms of science. Consequently, the question of the demand for strategic 
autonomy does not arise. However, neither ‘knowledge worker’, nor 
‘scientist’ are unproblematic terms and in both cases may refer to 
someone doing high level, specialised and independent work, or someone 
whose role is closer to that of a laboratory technician, involving a degree 
of skill. The implication is that this cannot be assumed to be an 
homogenous group with comparable qualifications, skills or knowledge, 
autonomy, career expectations or rewards (Randle 1996). 
 
In order to develop climates within which creativity can flourish, 
organisational structures, HRM techniques and management styles 
should, it is widely felt, accommodate the requirements of scientific 
professionals.  This, nevertheless, has to be done in a climate where the 
environment is increasingly competitive and both new product and 
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process development must take place alongside continuing pressure to 
improve productivity.  In tracing the history of R&D management 
some authors (de Leede et al [1994],  Rousel et al [1991]  Whittington 
[1991] ) identify a developing emphasis on the integration of R&D with 
increasing management control of the process and a consequent limitation 
on the degree of autonomy available to R&D workers.  
 
The dynamic underlying the context in which science takes place, will 
inevitably have an impact on the experience scientists have of their work.  
Much of the literature concerned with scientists fails to capture this point, 
assuming a timeless tension between the expectations of scientists and 
the goals of science-based organisations. This conflict may have been 
present, but of little real concern, during the unparalleled growth of these 
organisations after World War Two. However, as competition has 
heightened a need for greater control over the activities of scientists has 
developed. 
  
 
4. The Pharmaceutical Industry: From Golden Age to Age 
of Uncertainty 
 
4.1 1950 to 1990: The ‘Golden Age’  
 
The roots of the modern pharmaceutical industry can be traced back to 
the mid-nineteenth century (Bogner 1996). However, the period between 
1950 and 1990 has been described as ‘a golden age’ for the industry 
(Pisano 1997) with its foundations in methods of drug research which 
developed shortly after the Second World War (Ballance, Pogany and 
Forstner 1992).  
 
Methods of drug research deployed in the industry at this time were not 
sophisticated, rather they were ‘tedious and sometimes cruel’ (Ballance et 
al 1992) and the retention of an essentially trial and error methodology, 
was the major cause of the slowdown in drug development by the 
beginning of the 1960s.  Many of the new products which entered the 
market at this time were ‘me too’ drugs; near substitutes for existing 
products and not representing significant therapeutic advances.  
 
With the advent of rational drug design, a true technological revolution in 
drug development, an acceleration in discovery began. Behind this was 
the growing understanding of human biochemistry which reversed the 
traditional logic employed in drug discovery. Rather than screening to find 
new compounds and then finding out what they do, scientists could first 
determine what condition they wished to treat and design a compound to 
fit. Serendipity was no longer the source of innovation.   
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At the same time, an economic trigger to the growth of the ethical 
(prescription drug) industry was provided by the post war development of 
socialised medicine (Froud et al 1997).  This allowed medication to be 
paid for through either social insurance, corporate welfare or private 
insurance schemes and market growth rates during the 1970s and 1980s 
suggested a recession proof industry. The outcome of this, it has been 
argued (Randle 1996) is that the ‘golden age’ benefited both the big 
pharma companies and their R&D staff who, in a tight labour market, 
could command premium pay and conditions, job security, and predictable 
careers. 
 
By the mid 1980s the promise of biotechnology, a further extension of 
rational drug design, began to overshadow the developing interdisciplinary 
approaches of the still chemistry-based rational methodologies, 
representing a significant threat to the research base of the traditional 
pharmaceutical firm. Many of the competences required for this research 
are based within newer, smaller, biotechnology companies. The barriers to 
entry into the industry that operated in previous decades have, as a result, 
been lowered.  
 
 
4.2 The 1990s onwards: An Age of Uncertainty 
   
Changes in the economic environment led to far less favourable 
conditions for the Pharma industry during the 1990s with sharp increases 
in R&D costs prompted by longer testing requirements for new products. 
The consequently shorter patent lives led to increasing difficulty in 
recouping investment at a time when there was considerable pressure on 
public authorities to cut healthcare costs (Randle and Rainnie 1997). In 
the US over the same period drug pricing became a key competitive tactic 
as new products were introduced not at a premium as in the past, but at a 
discount (Longman 1995). The picture is now much less rosy for the R&D 
based prescription drug company (Froud et al 1997). 
  
During the 1990s changing structural conditions resulted in very significant 
global restructuring of the industry. Mergers between ethical drugs 
producers, the result of pressures some of which are directly related to 
R&D (Tompkins 1996)1  has led to an increasing concentration within the 
industry. Following mergers companies have cut payroll and closed sites 
shattering the stability evident from the early 1960s to the end of the 
                                                          
1 These include;  the need to control rising R&D costs;  the need for rationalisation;  
falling profits;  the globalisation of the market;  the need to buy out the opposition;  the 
desire for greater market share;  the need for growth;  deteriorating returns on R&D;  a 
need for synergy in R&D; and pressure to consolidate the infrastructure of an over-
fragmented market.  
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1980s and have ‘unsettled scientists and managers alike’ (Ballance et al 
1992).  The anticipated outcome is a bigger market share, reduced 
competition and reduced costs as headcount declines.  
 
It is also possible that newer drug discovery technologies may result in a 
greater separation between the intellectual and the more routine aspects 
of pharmaceutical R&D, thus impacting further upon those employed in 
research.  In its turn and combined with greater use of short-term 
contracts, agency workers and outsourcing of research to smaller 
biotechnology companies, opportunities for companies to further 
rationalise workforces may occur and may lead to a changing division of 
labour in the laboratory (Randle 1966). 
 
The hallmarks of the industry from the 1960s onwards are consequently 
being eroded, leading Ballance et al (1992:175) to observe that: “ Drug 
producers…are competing much harder with rivals.…the pharmaceutical 
industry is losing some of its uniqueness and becoming more like other 
parts of the manufacturing  sector.”  In turn those employed in high status 
occupations within it have found themselves subject to a changing 
employment relationship which has undermined their relatively privileged 
position. 
 
 
5. Class and the Middle Layers of Employment 
 
A Marxist analysis (McKenzie 1982) argues that classes derive their 
identity and definition from the relationships between them: a class is not a 
self-contained entity which can be understood simply in terms of its 
internal characteristics. This has particular significance for the analysis of 
workplace behaviour, as the conflictual relationships inherent in the 
Marxist conception of class will be played out in some form which reflects 
the needs of capital to extract surplus value from labour at the point of 
production. Nevertheless, identifying the boundaries between classes at 
workplace level is fraught with difficulties. 
 
While Marx (1974) recognised the complexity of the class structure in 
England in his own lifetime, by the latter half of the twentieth century, new 
intermediate strata could be identified whose development has further 
increased the complexity of the division of labour and led to a more highly 
differentiated hierarchy of authority within organisations. Since Marx there 
have been a number of attempts within the Marxist perspective to amend 
class analysis in order to take account of this development. 
 
During the last twenty years this has resulted in three broad approaches.  
In the first this group is seen as constituting a 'new working class', a 
natural ally of the 'traditional' proletariat (Gorz 1967, Mallet 1975).  
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However the work of Mallet has been painted as flawed by technological 
determinism and national specificity, while Gorz emphasis on ideology in 
locating technical workers has resulted in charges of idealism (Smith 
1987).  By the 1980s Gorz was dismissing work as no longer central to 
class analysis (Gorz 1982). 
 
A second approach takes the view that the middle groupings constitute a 
separate 'professional managerial class' (Ehrenreich and Ehrenreich 
1979), a 'new petty bourgeoisie' (Poulantzas 1975), a 'new middle class' 
(Carchedi 1977) or a 'service class'  (Goldthorpe 1982, Abercrombie and 
Urry 1983). This second approach sees the working class becoming 
progressively smaller, while the ‘middle class’ grows.  While all of these 
approaches have their critics some have greater currency than others. 
One recent paper (Li et al 2002:617) comments that : 
 
‘in the last 15 years much work in the field of class analysis 
has centred on the contrast between the service class....and 
the working class. Furthermore this ‘structural distinction’ 
between the service and working classes, is seen as 
‘analytically powerful, has validity, and is not in question 
here’ 
 
This theory argues that a new ‘service class’ of organisation-based 
professions is emerging as an independent ‘third force’ between capital 
and labour in advanced societies. This group consisting of managers, 
administrators, scientists, technical experts and human services 
specialists is seen to constitute a potential force for socio-political change.  
It advances the cause for rationalisation in the name of meritocracy, equity 
and efficiency as against the values of privilege, preference and stability 
defended by traditional elites and ruling groups.  Organisational 
professions can be seen as a strategic source of moral regulation and 
cultural integration within increasingly differentiated and fragmented 
modern industrial societies (Reed 1992: 210). 
 
Goldthorpe (1982) and Abercrombie and Urry (1983) have proposed the 
existence of a service class as a theoretical response to the growth of the 
middle layers (Crompton and Jones 1984).  It is characterised as a ‘class 
in itself’ which has a recognisable set of interests and which cannot be 
understood simply from its intermediate position between capital and 
labour. It is capable of becoming a meritocratic ‘class for itself’ whose 
interests are most clearly served by credentialism as an exclusionary 
strategy and political strategies that stabilise capitalist relations of 
production. 
 
Central to the relationship between the employer and the middle layers in 
Goldthorpe's (1982) work is ‘trust’. Employees gain conditions of 
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employment and rewards which reflect this relationship.  The employer 
requires service class members to accept delegated authority (managers) 
and give access to their specialised knowledge and expertise 
(‘professionals’).  Goldthorpe combines these roles on the basis of the 
high degree of autonomy and discretion that both incorporate. 
 
Abercrombie and Urry (1983) are heavily dependent on the notion of 
career for defining the service class.  This ensures members a fairly 
predictable trajectory through the organisational hierarchy of 
bureaucracies which function as internal labour markets. As individuals 
move up the hierarchy they will experience improved pay and conditions, 
increasing authority and discretion and greater opportunity for creativity 
and self-control. 
 
A contrasting third perspective sees the middle layers as occupying a 
'contradictory class location' (Wright 1978), 'a structurally ambiguous 
position' (Crompton and Jones 1984) or as otherwise placed in no fixed 
position between the proletariat and the bourgeoisie (Braverman 1974, 
Callinicos 1983).  The middle strata are regarded within this perspective 
as a distinct group though not a separate class. In the capitalist 
organisation these strata may share the characteristics of the manager or 
workers to varying degrees and will be pulled simultaneously in both 
directions. Class position is seen as something fluid rather than fixed and 
amongst those with only labour power to sell there can exist different 
relations of production.   For Braverman defining the actual class position 
of a given group remains difficult in that we are not confronting a fixed 
entity but rather : 
 
‘…ongoing processes, rich in change, transition and 
variation, and incapable of being encapsulated in formulas, 
no matter how analytically proper such formulas may be…’ 
(1974:409) 
 
 
 
6. Pharmco: Experiencing professional work in a changing 
environment 
 
It has been reported elsewhere (Randle and Rainnie 1997) that freedom 
of investigation, through relatively loose control structures, were seen by 
Senior managers at Pharmco as vital in promoting an atmosphere within 
which effective research could take place.  However pressure to produce 
drugs meant that this was balanced by an increasingly ruthless approach 
to culling projects where no profitable outcome could be predicted. It was 
nevertheless accepted by managers at Pharmco that there is a degree of 
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indeterminacy in scientific research which means that management 
cannot always know what individual scientists are doing.  
 
 Across the research grades as a whole, interviews suggested, there was a 
relatively high degree of operational autonomy at Pharmco. However, at 
the lower levels a degree of supervision existed which meant that even 
day to day operational goals were set by someone more senior. Targets 
were set for the individual researcher such that there may be little real 
choice in what to do, the choice simply rests in how the work is to be 
structured within quite strict constraints.  
 
The possession of a PhD was an important indicator of the freedom of 
action scientists could expect and this was closely related to placement on 
the R5 (Research) grade and above. There was evidence that having 
reached this stage the employee could be expected to have internalised 
the need to pursue project goals and would be handling her/his autonomy 
in the ‘responsible’ manner.  
 
Project Leaders, taking on some management functions within the matrix 
structure, also had their projects to protect and would thus apply a degree 
of pressure to those lower down the hierarchy to deliver, while formally 
encouraging an element of tangential, more speculative work by team 
members.  Failure to make progress could be fatal for the project.  
  
More junior staff reported having no say in determining the future of 
projects. Strategic autonomy, for example, the selection of which 
therapeutic areas to target or the setting up and closing down of projects 
is very much in the hands of Senior Management.  Even amongst the 
most senior scientists the limits of autonomy do not stretch to strategic 
decision making. In practice, as this section will demonstrate, there are 
also considerable restraints on individual freedom.  
 
  
6.1 Managing Creativity 
 
‘Ten per cent time’ 
 
During the earlier stages of the study there were a number of references 
by more senior managers to ‘ten per cent time’. Scientists were apparently 
encouraged to spend approximately half a day per week working on ideas 
not directly related to a therapeutic project that might prove to have some 
incidental value to the company. However, while managers or those 
higher up the research grade hierarchy believed tangential work to be 
important and believed that it was encouraged, those lower down the 
research grades were far more cynical about the extent of the opportunity 
to carry out such work in practice. Ann, an R2 Biologist reports;  
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 ... I’m a screening machine, which is OK because,  you 
know, you can do it with your eyes shut,  but it would be nice 
if I could go off to the library and read a couple of papers… 
 
By the second interview round there was evidence that the notion of 
autonomous research was now being heavily squeezed by the emphasis 
on measurable productive output, reflected in progress towards project 
targets. No-one referred to 10% time any longer. 
 
 
‘Trust time’ 
 
During the first interview round respondents were also asked about the 
move from flextime to ‘trust time’. This system replaced the requirement to 
spend an average of 37.5 hours per week on the premises measured by 
an individual clock, with one in which staff were expected to monitor their 
own working time outside of core hours.  The flex system meant that hours 
accumulated each month above the target could be banked towards days 
off. Under trust there was no entitlement to compensation for excess 
hours, but line managers had discretion to allow time off where it was felt it 
could be justified. This was seen as creating an environment which puts 
less emphasis on bureaucratic ‘presenteeism’ and more on innovative 
activity as, for example, performance in the eyes of line managers would 
be one criterion upon which time off was awarded. 
 
Many staff raised objections to the system, maintaining that the overall 
outcome was that they spent more time at work without a right to 
compensation. There was little disagreement that less time was now being 
taken off by the time of the second interview round. A Senior Research 
Biologist commented that; 
  
 ... it works well, from the company’s point of view, everyone 
is working longer hours than they used to ... 
 (Ben) 
 
The Trust system appeared to have two benefits for management: firstly, 
in abandoning formal monitoring they actually achieved higher levels of 
attendance (less days taken off per year). Secondly, the role of line 
management in dispensing time off has the effect of pushing people to 
actively demonstrate high levels of performance and thereby make more 
transparent the indeterminacy of professional work. The shift to paying for 
performance with the introduction of a PRP system, rather than paying for 
attendance has a similar logic and the functions and dysfunctions of both 
HR practices in R&D have been reported extensively elsewhere (Randle & 
Rainnie 1997, Randle 1996, 1997, 1999). 
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6.2 Merger and Redundancy 
  
The way in which the post-merger integration process of Pharmco and 
Drugco was approached in the UK had considerable impact upon 
employee morale. Once the new structure of the organisation had been 
determined by the most senior managers and middle managers had been 
appointed, research staff at laboratory level who wished to stay were 
required to apply for jobs in the new, smaller ‘units’, which replaced the 
previous, scientific discipline based, departmental structure. 
 
The process took some time and caused widespread anxiety amongst 
employees. However, the relative privilege, which the research grades at 
Pharmco had enjoyed prior to the merger seems to have obviated the 
need for collective approaches to workplace issues in earlier years.  There 
was a low union membership amongst those interviewed and this, it is 
understood, is reflected across research at Pharmco as a whole. The MSF 
union was not recognised for collective bargaining purposes but solely for 
individual representation.  In all, about one third of the workforce in 
Research left as a result of either compulsory or voluntary redundancy.  
 
The fate of those who had applied for positions in the Research Division of 
the merged organisation were communicated in a single day in which all 
staff were asked to report on site at timed intervals. The day was 
colloquially referred to as ‘Black Monday’. The significance of the 
redundancy process, which appeared to have eluded the designers, was 
not lost on those who took part in interviews, although all of those who are 
quoted below were given ‘good news’.  The symbolism implicit in those 
who were to ‘survive’ being sent along a corridor to the left, while the 
‘victims’ of the process were sent to the right, had clearly left a strong 
impression, and was mentioned by many interviewees : 
 
 ... depending on whether you were going to be made 
redundant or stay in the company you went sort of one way, 
or the other ... sort of to the gas chamber...    (Bob, Unit 
Head) 
 
 ...there was this joke going around for a couple of months 
afterwards ....... How do you scare a Pharmco2 scientist? 
.....Tell him to turn right  (laughs) ...           (Nick, Senior 
Research Manager) 
 
 16
While interviewees had differing perceptions of the rationale behind 
redundancy decisions, there seems to be a broad consensus that 
possession of scientific skills was a key factor.  Some skills, such as those 
of molecular biology were in short supply, while classical pharmacological 
skills were over-represented in the organisation. Changes in scientific 
technologies suggested that this balance should be changed.  Individual 
performance appears to be a secondary criterion. The  company was able 
to choose between those with the required scientific skills using PRP data, 
individually produced career summaries and a managers report. 
 
The process was seen as one which could produce a downsized 
organisation, better placed technologically to address the challenges 
perceived as facing pharmaceutical research. Intensifying competition 
required an organisation committed to reducing the time taken to deliver 
new drugs to the marketplace.  
 
The research organisation had been delayered, as part of this process, to 
take out middle management jobs which were not explicitly connected with 
the management of research in the laboratory. The result was a flatter 
structure based more closely on the drug discovery process.  
 
Within the new organisation a previously identified rift between exploratory 
and therapeutic research seemed to be growing, not only in terms of the 
technologies involved, but also as a result of a ‘them and us’ attitude 
developing between more and less basic research teams.  
 
A senior member of the Human Resources team described how in the 
past : 
 
 ...there was a sort of psychological contract, which was that 
if you keep your nose clean and do a good  job you will 
retire here and that was very much the way people felt ... 
that has gone completely...  
 
The company signalled the view that a job with Pharmco should not be 
considered a job for life, through changing benefit programmes. The 
symbolism of the,  ‘portable’ pension, for example, was powerful and the 
message was not lost on staff. However it did prompt them to think about 
what a ‘changing relationship’ entails. Commitment or loyalty is a ‘two-way 
street’ . 
 
The consensus appeared to be that the research work still provided many, 
especially the more senior scientists, with a relatively high degree of 
intrinsic interest. Many mentioned the satisfaction in the science itself, 
whereas the organisational changes, the new structures and the method 
of their implementation, as well as the sense of insecurity which arises 
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from a lack of confidence in the future, gave rise to cynicism, low morale 
and lack of commitment: 
 
 ... I’ve got a very interesting  job …..but I think its sad, the 
atmosphere that’s developed around here... there are a lot 
of very cynical people who are pretty fed up with it ….. it is a 
lot more pleasant to work in a place where people enjoy 
their work and see where they’re going ... 
 (Pam)  
 
Market turbulence vividly demonstrates the limits on the ability of the 
merged organisation to control the environment within which it operates. 
To ensure its future the company will be forced to continue to seek larger 
shares of the pharmaceutical market in competition with others and indeed 
this prediction by many staff was subsequently borne out. 
 
Cynicism about the new company was reflected in attitudes, not only 
about the merger process, but about other organisational changes which 
had resulted in cost cutting and the intensification of work in order to 
heighten competitiveness: 
 
 ...the more time you spend within this company, certainly 
recently, the more you realise that everything is……trimmed 
down as much as possible,  lets make everyone as 
absolutely efficient as possible, lets cut those costs right 
down to the bare minimum, lets maximise the number of 
millions of pounds that each employee gives to the company 
or brings to the company  in terms of profit... 
 (Bernie, Chemist) 
 
It has been noted elsewhere that mergers and acquisitions have been 
associated with high levels of voluntary resignation that have been termed 
‘the post acquisition drift factor’ or ‘the haemorrhage effect’ (Cooper and 
Cartwright 1996: 45).  It could plausibly be argued that after a period of 
upheaval, a level of normality will return and the previous relationship 
might be reconstituted. In this case however, continued instability in the 
environment for pharmaceuticals militates against a foreseeable return to 
the conditions of the ‘golden age’ after 1950. 
 
What many similar groups of employees have experienced earlier as a 
result of ‘shake-outs’ following the end of the post-war long boom or the 
privatisation of formerly state-owned utilities have now taken hold in the 
pharmaceutical industry as a consequence of environmental change. 
 
Scientists at Pharmco came to understand that their employing 
organisation was not committed solely to organic growth through 
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discovery and development of new medicines but was prepared to use 
merger and acquisition as a method of achieving a greater share of the 
market for ethical drugs.  Along with this came a realisation that the 
company did not offer jobs for life and that greater insecurity now 
characterised work in the industry. 
 
 
7. Conclusion 
 
In considering the location of the middle layers of employment against 
data derived from the case, this paper finds weaknesses in the notion of a 
service class both theoretically and in practice. Three criticisms are most 
apparent. Firstly, in efforts to define the limits of the class, the  ‘boundary 
problem’ remains.  At the margins where do we draw the line between the 
service class and routine clerical workers, technicians and supervisors on 
the one hand and the capitalist class on the other?  An associated 
problem is that service class theorists seem to attribute an homogeneity to 
the professional/ administrative/ managerial strata which is not borne out 
by the Pharmco data.  Definitions of ‘scientist’, as we have seen, are 
extremely broad and include the most qualified, highly paid and senior 
with the greatest operational autonomy and degrees of responsibility and 
others doing far more routine work with little freedom of action.   
 
In the case described here, the most senior staff had the power to hire and 
fire, deciding during ‘Black Monday’ who would stay with the organisation 
and who would be made redundant. This notion of a service class 
seriously underestimates the potential for conflict between groups in the 
centre of the hierarchy acting out their organisational roles.  In this case 
the potential was made real by the changing economic environment which 
first required line managers to implement new devices for increasing 
efficiency and then placed more senior managers in a position of having to 
decide who stayed and who would leave Pharmco. 
 
A second criticism of the service class thesis is that it understates, or 
ignores, the extent to which organisational professionals of all types are 
dependent on and subordinate to the power of economic elites, both within 
and external to the organisation.  Within Pharmco the most senior 
managers made key resource decisions, for example, about project lives.  
These decisions were made, not on the basis of the viability of the science 
involved or the presence of a target for the drug, but on its market 
potential. In this case, researchers who may feel that certain projects have 
scientific merit or significant value to some sections of the community, had 
been relocated to work on what they described as ‘lifestyle’ drugs.  
Externally the markets proved powerful and the industry as a whole was in 
flux as a continuing trend towards concentration of capital resulted in a 
wave of mergers and acquisitions. 
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A third and perhaps most telling criticism is that the idea of an 
‘autonomous’ service class, capable of furthering its own interests, seems 
a contradiction in terms and that this stratum should be seen as in ‘a 
highly contingent relationship of rewards for its “faithful service” ‘ 
(Crompton and Jones 1984:225).  This has become more apparent in 
recent times, for while much of this debate was carried on in the early 
1980s the fragility of the relationship between the middle and upper layers 
of employment has been demonstrated during the 1990s.  For R&D 
scientists the Pharmaceutical industry during its ‘Golden Age’ offered 
significant rewards, job security and an assured career structure. For 
scientists at Pharmco the merger described in this paper and the 
organisational restructuring meant that both job security and steps up a 
long career ladder have largely disappeared. The scale of ‘downsizing’ 
and ‘delayering’ across organisational hierarchies, perhaps epitomised by 
those formerly in the public sector which seemed to represent the 
corporatist future most clearly, have undermined the idea of a growing 
class on route to dominance.  
 
Marxist theories of class and labour process theories concerned with 
management control do have significant explanatory power when applied 
to the interview data presented here. When the space for reassessment of 
the employment relationship is created, such as happened during the 
Pharmco merger, the relationship between the company and its 
employees is not a fixed or stable entity. Under these circumstances a 
dynamic and non-deterministic approach to analysis which can 
accommodate the notion of class as a fluid and changing phenomenon, 
and the development of the labour process as complex and non-linear, will 
provide most illumination. 
 
There is, it is argued here, no contradiction in representing highly 
qualified, relatively well paid, white collar professionals who comprise the 
middle layers of organisations, as sharing a set of objective interests with 
the ‘traditional’ working class. The middle layers may represent a distinct 
grouping, occupying an ambiguous or contradictory position, but they do 
not constitute a separate (service) class. They will share the 
characteristics of both manager and worker to varying degrees and may 
be pulled simultaneously in both directions. However, the dynamic 
inherent in the capitalist mode of production ensures that even ‘privileged’ 
employees cannot count on maintaining that privilege indefinitely and the 
subjective experience of this group may shift over time to more closely 
reflect an objective assessment of its class location as increasingly 
proletarianised. Rather than witnessing the death of the working class, we 
may conclude, we are seeing it transformed and re-generated. 
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We must remain aware, then, of the contradictory nature of the capital-
labour relationship which contains elements of both conflict and 
cooperation. Furthermore we must avoid imputing from the fact that 
cooperation must, in practice, exist for organisations to continue to 
operate,  that workers necessarily accept management actions as 
legitimate.  Finally, while the reality of class at work can be seen as 
intimately related to questions of control, hierarchy, privilege and 
autonomy the task is not to identify class boundaries and draw the 
resulting map but rather, as Smith and Willmott have suggested,  ‘... to 
analyse how the processes of capitalism are practically organised within 
the sphere of work ...’ (1991:29). 
 
 
 
 
Keith Randle September 2003 
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